...patients: one with elevated mutation rates in p53 and α thalassemia/mental retardation syndrome X-linked (ATRX; RAD54...
...Zurich, Basel, Switzerland email: jack.kuipers@bsse.ethz.ch CONTACT: Niko Beerenwinkel, same affiliation as above email: niko.beerenwinkel@bsse.ethz.ch Claire Quang ETH Zurich Alpha thalassemia/mental retardation syndrome X-linked (ATRX) (RAD54) Capicua...

...FDA's list names both targets individually. ASCL1(MASH1) - Achaete-scute family bHLH transcription factor 1; ATRX (RAD54...

...TECHNOLOGY: Transgenics and knockouts Mice with p53 knocked out, ATRX knocked down and both PDGFRA and...
...high-grade gliomas. In mice, embryos engineered in utero for cortical neural progenitor cell-specific p53 knockout, ATRX...
...screen for therapies. DESCRIPTION: Mice with p53 knocked out, α thalassemia/mental retardation syndrome X-linked (ATRX; RAD54...

...Anderson Cancer Center University of Wisconsin-Madison Unum Therapeutics Inc. 4-1BB ligand (4-1BBL) (TNFSF9) (CD137L) Additional sex combs like 1 (ASXL1) Alpha thalassemia/mental retardation syndrome X-linked B...

...II TATA box binding protein (TBP)-associated factor (TAF12) ; nuclear transcription factor Y γ (NFYC); RAD54-like...

...tumors Multiple endocrine neoplasia I (MEN1; menin); death-domain associated protein (DAXX); a-thalassemia/mental retardation syndrome X-linked (ATRX...
...tumors. In pancreatic neuroendocrine tumors isolated from patients, mutation rates for the MEN1, DAXX and ATRX...
...had a 14% mutation rate. In patients with pancreatic neuroendocrine tumors, MEN1 mutations together with ATRX...

...in Nature Neuroscience , that team identified multiple transcription factors-including a-thalassemia/mental retardation syndrome X-linked (ATRX; RAD54...

...for use in other indications D. 4/5/01 - Obtains exclusive European marketing rights from Atrix (ATRX...

...resolves their dispute with CMS.H. 6/14/04 -QLT announces plans to buy Atrix. The deal includes ATRX's...

...ATRX share held (see BioCentury, June 21). Using QLTI's Nov. 19 close of $15.42 and ATRX's...
...about $300 million in cash. ATRX Chairman and CEO David Bethune retired. Atrix Laboratories Inc. (ATRX...